DA
Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
$21.53 +0.00% (+$0.00)
Market Cap $2.22B
P/E Ratio -
Div. Yield -
ROE 32.05%
Bulios Fair Price
$18.02
16.3% downside
Trenutna cena
$21.53
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DAWN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
19 /100
Expensive P/B 4.93x
P/S 16.64x
PEG N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
20 /100
Weak FCF margin 90.79%
Op. margin 123.90%
Gross margin 89.44%
Quality
3 /100
Poor Asset turnover 0.26x
ROA 29.54%
ROIC 37.82%
Debt
100 /100
Low Current ratio 8.68x
Net debt/EBITDA 0.28x
Debt/Equity 0.01x
Stability
45 /100
Moderate EPS volatility 34.05%
Profitable years 0
Beta -1.75x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DAWN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeremy Bender
Employees
181
Headquarters
Brisbane